» Authors » Heather L Stevenson

Heather L Stevenson

Explore the profile of Heather L Stevenson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 736
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Millian D, Arroyave E, Wanninger T, Krishnan S, Bao D, Zhang J, et al.
medRxiv . 2025 Mar; PMID: 40034770
Lay Summary: Direct-acting antiviral (DAA) therapy has dramatically improved the treatment of chronic HCV, making it curable for most people. This study determined gene and protein expression differences in the...
2.
Bowen C, Ditmars F, Liu N, Abril J, Ajasin D, Russell W, et al.
bioRxiv . 2025 Mar; PMID: 40027749
Regardless of the source of injury or metabolic dysfunction, fibrosis is a frequent driver of liver pathology. Excessive liver fibrosis is caused by persistent activation of hepatic stellate cells (HSCs),...
3.
Arroyave E, Saldarriaga O, Bhatti S, Bergman I, Graham R, Tana M, et al.
Mod Pathol . 2025 Feb; 38(5):100728. PMID: 39914772
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are immune-mediated liver diseases (IMLDs) that are diagnosed by a combination of clinical, serologic, and histologic features. Diagnosis may be challenging, particularly...
4.
Johnson J, Engebretsen T, Mujtaba M, Stevenson H, Kulkarni R, Lea A, et al.
Surg Pract Sci . 2025 Jan; 16():100236. PMID: 39845340
Introduction: In renal transplantation, donor hepatitis C virus (HCV) status is crucial to consider when selecting a recipient given the high likelihood of transmission. We analyzed the effect of donor...
5.
Wanninger T, Saldarriaga O, Arroyave E, Millian D, Comer J, Paessler S, et al.
Front Immunol . 2024 Dec; 15:1439971. PMID: 39635525
Background: The inflammatory macrophage response contributes to severe Ebola virus disease, with liver and lung injury in humans. Objective: We sought to further define the activation status of hepatic and...
6.
Koi A, Johnson J, Engebretsen T, Mujtaba M, Lea A, Stevenson H, et al.
J Pers Med . 2024 Nov; 14(11). PMID: 39590598
Background/objectives: With kidney transplant immunosuppression, physicians must balance preventing rejection with minimizing infection and malignancy risks. Steroids have been a mainstay of these immunosuppression regimens since the early days of...
7.
Johnson J, Malik M, Engebretsen T, Mujtaba M, Lea A, Stevenson H, et al.
Drugs Aging . 2024 Oct; 41(11):915-927. PMID: 39417973
Background: Steroids are widely used in maintenance immunosuppression treatment in kidney transplant recipients. Older individuals undergo age-related immunosenescence that consequently decreases their ability to process and evoke a response to...
8.
Dolapchiev L, Gonzales K, Cruz L, Gagea M, Stevenson H, Kwan S, et al.
J Hepatocell Carcinoma . 2024 Oct; 11:1891-1905. PMID: 39372712
Purpose: Hepatocellular carcinoma (HCC) related to metabolic dysfunction-associated steatotic liver disease (MASLD) is often diagnosed at a late stage, and its incidence is increasing. Predictive biomarkers are therefore needed to...
9.
Cicalese L, Walton Z, Du X, Kulkarni R, Qiu S, Hag M, et al.
Transpl Int . 2024 Sep; 37:13232. PMID: 39267618
The diagnosis of liver antibody-mediated rejection (AMR) is challenging and likely under-recognized. The association of AMR with donor-specific antibodies (DSA), and its clinical course in relation to pathologic findings and...
10.
Kwan S, Gonzales K, Jamal M, Stevenson H, Tan L, Lorenzi P, et al.
Gut Microbes . 2024 Sep; 16(1):2399260. PMID: 39239875
The gut microbiota drives progression to liver fibrosis, the main determinant of mortality in metabolic dysfunction-associated steatohepatitis (MASH). In this study, we aimed to identify bacterial species associated with protection...